MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 4 (2007), Issue 3 (March)

1. Staphylococcal cassette chromosome mec and Panton-Valentine leukocidin characterization of methicillin-resistant Staphylococcus aureus clones.
   J Clin Microbiol, 45(3): 1019-21. [Abstract] [Full-text]
2. Identification of the capsular polysaccharides in Staphylococcus aureus clinical isolates by PCR and agglutination tests.
   J Clin Microbiol, 45(3): 725-9. [Abstract] [Full-text]
3. Staphylococcus aureus strains isolated from bloodstream infections changed significantly in 2006.
   J Clin Microbiol, 45(3): 851-7. [Abstract] [Full-text]
4. Community-associated methicillin-resistant Staphylococcus aureus hand infections in an urban setting.
   J Hand Surg [Am], 32(3): 380-3. [Abstract] [Full-text]
5. Extensive multidrug resistance of coagulase-negative staphylococci in medical students.
   J Infect Chemother, 13(1): 63-6. [Abstract] [Full-text]
6. Methicillin-resistant Staphylococcus aureus in critical care areas.
   Crit Care Nurs Clin North Am, 19(1): 61-8. [Abstract] [Full-text]
7. A Combinatorial Approach to the Discovery of Biocidal Six-Residue Cyclic d,l-alpha-Peptides Against the Bacteria Methicillin-Resistant Staphylococcus aureus (MRSA) and E. coli and the Biofouling Algae Ulva linza and Navicula perminuta.
   Chemistry. [Abstract] [Full-text]
8. Antimicrobial activities of some tetrahydronaphthalene-benzimidazole derivatives.
   Chemotherapy, 53(2): 110-3. [Abstract] [Full-text]
9. Prevalence and Characteristics of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus (hVISA) Bacteremia in a Tertiary Care Center.
   J Clin Microbiol. [Abstract] [Full-text]
10. Oral beta-lactams applied to uncomplicated infections of skin and skin structures.
    Diagn Microbiol Infect Dis, 57(3): S55-65. [Abstract] [Full-text]
11. A stochastic mathematical model of methicillin resistant Staphylococcus aureus transmission in an intensive care unit: predicting the impact of interventions.
    J Theor Biol, 245(3): 470-81. [Abstract] [Full-text]
12. Detection of low-level oxacillin resistance in mecA-positive Staphylococcus aureus.
    Clin Microbiol Infect, 13(4): 408-12. [Abstract] [Full-text]
13. Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection?
    Clin Microbiol Infect, 13(4): 351-3. [Abstract] [Full-text]
14. Look before you leap: active surveillance for multidrug-resistant organisms.
    Clin Infect Dis, 44(8): 1101-7. [Abstract] [Full-text]
15. Risk factors for isolation of low-level mupirocin-resistant versus -susceptible methicillin-resistant Staphylococcus aureus from patients in intensive care units.
    J Infect, 54(4): 337-42. [Abstract] [Full-text]
16. Emergence of community-associated methicillin resistant Staphylococcus aureus in Hawaii, 2001-2003.
    J Infect, 54(4): 349-57. [Abstract] [Full-text]
17. Anti-MRSA beta-lactams in development, with a focus on ceftobiprole: the first anti-MRSA beta-lactam to demonstrate clinical efficacy.
    Expert Opin Investig Drugs, 16(4): 419-29. [Abstract] [Full-text]
18. Comparison of four chromogenic media for culture-based screening of meticillin-resistant Staphylococcus aureus.
    J Med Microbiol, 56: 500-3. [Abstract] [Full-text]
19. Evaluation of a chromogenic agar (MRSASelect) for the detection of meticillin-resistant Staphylococcus aureus with clinical samples in The Netherlands.
    J Med Microbiol, 56: 491-4. [Abstract] [Full-text]
20. Semisynthetic approaches to laspartomycin analogues.
    J Nat Prod, 70(3): 447-50. [Abstract] [Full-text]
21. Epidemiological typing of methicillin-resistant Staphylococcus aureus strains by Fourier transform infrared spectroscopy.
    J Microbiol Methods, 69(1): 146-53. [Abstract] [Full-text]
22. In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
    Antimicrob Agents Chemother, 51(4): 1259-67. [Abstract] [Full-text]
23. Pharmacokinetic/pharmacodynamic factors influencing emergence of resistance to linezolid in an in vitro model.
    Antimicrob Agents Chemother, 51(4): 1287-92. [Abstract] [Full-text]
24. Quality of data reported to a smaller-hospital pilot surveillance program.
    Infect Control Hosp Epidemiol, 28(4): 486-8. [Abstract] [Full-text]
25. Development of a surveillance system for methicillin-resistant Staphylococcus aureus in German hospitals.
    Infect Control Hosp Epidemiol, 28(4): 446-52. [Abstract] [Full-text]
26. Risk factors for neonatal methicillin-resistant Staphylococcus aureus infection in a well-infant nursery.
    Infect Control Hosp Epidemiol, 28(4): 406-11. [Abstract] [Full-text]
27. Glomerulonephritis induced by methicillin-resistant Staphylococcus aureus infection that progressed during puerperal period.
    Clin Exp Nephrol, 11(1): 92-6. [Abstract] [Full-text]
28. Community-associated methicillin-resistant Staphylococcus aureus skin infections in a religious community.
    Epidemiol Infect, 135(3): 492-501. [Abstract] [Full-text]
29. Methicillin-resistant Staphylococcus aureus infectious keratitis following refractive surgery.
    Am J Ophthalmol, 143(4): 629-34. [Abstract] [Full-text]
30. Probability of Target Attainment for Ceftobiprole as Derived from a Population Pharmacokinetic Analysis of 150 Subjects.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
31. Potent, synergistic inhibition of Staphylococcus aureus upon exposure to a combination of the endopeptidase lysostaphin and the cationic peptide ranalexin.
    J Antimicrob Chemother, 59(4): 759-62. [Abstract] [Full-text]
32. Comparison of an enrichment broth-enhanced commercial PCR procedure versus bacteriological culture for separating non-colonized from suspected or colonized MRSA individuals.
    Eur J Clin Microbiol Infect Dis, 26(3): 155-60. [Abstract] [Full-text]
33. Macrolide-lincosamide-streptogramin B resistance phenotypes and genotypes among Staphylococcus aureus clinical isolates in Japan.
    Clin Microbiol Infect, 13(3): 325-7. [Abstract] [Full-text]
34. Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals.
    Clin Microbiol Infect, 13(3): 269-76. [Abstract] [Full-text]
35. Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients.
    Clin Microbiol Infect, 13(3): 264-8. [Abstract] [Full-text]
36. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Spain: a multicentre prevalence study (2002).
    Clin Microbiol Infect, 13(3): 250-6. [Abstract] [Full-text]
37. Comparative genomics and DNA array-based genotyping of pandemic Staphylococcus aureus strains encoding Panton-Valentine leukocidin.
    Clin Microbiol Infect, 13(3): 236-49. [Abstract] [Full-text]
38. The molecular evolution of methicillin-resistant Staphylococcus aureus.
    Clin Microbiol Infect, 13(3): 222-35. [Abstract] [Full-text]
39. MRSA enteritis causing a high stoma output in the early postoperative phase after bowel surgery.
    Ann R Coll Surg Engl, 89(3): 303-8. [Abstract] [Full-text]

© 2004-2012 MRSA Research Today. All Rights Reserved.